Acute effects of tibolone on cerebral vascular reactivity in vitro

Climacteric

Volumn 6, Issue 3, 2003, Pages 228-237

  Lund, C O ^a   Nilas, L ^a   Dalsgaard, T ^a   Pedersen, S H ^a   Ottesen, B ^b  

^a HVIDOVRE HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

Calcium; Cerebral arteries; Estradiol; In vitro; Nitric oxide; Rabbit; Tibolone; Vasodilatation

Indexed keywords

3ALPHA HYDROXYTIBOLONE; 3BETA HYDROXYTIBOLONE; CALCIUM; DRUG METABOLITE; ESTRADIOL; N(G) NITROARGININE METHYL ESTER; POTASSIUM; POTASSIUM CHANNEL BLOCKING AGENT; PREGNANE DERIVATIVE; TETRYLAMMONIUM; TETRYLAMMONIUM CHLORIDE; TIBOLONE; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ADRENERGIC SYSTEM; ANALYSIS OF VARIANCE; ANIMAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BRAIN; BRAIN ARTERY; BRAIN BLOOD VESSEL; BRAIN VASCULAR RESISTANCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; EVALUATION; FEMALE; HORMONE ACTION; IN VITRO STUDY; ISOMERISM; METABOLISM; MUSCLE ISOMETRIC CONTRACTION; MYOGRAPHY; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; RABBIT; RANDOMIZATION; STUDENT T TEST; VASCULAR RESISTANCE; VASCULARIZATION; VASODILATATION;

EID: 0141727797     PISSN: 13697137     EISSN: None     Source Type: Journal    
DOI: 10.1080/cmt.6.3.228.237     Document Type: Article

References (35)

1. Mosca L, Manson JE, Sutherland SE, Langer RD, Manolio T, Barrett-Connor E. Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group. Circulation 1997;96:2468-82
2. Manolio TA, Kronmal RA, Burke GL, O'Leary DH, Price TR. Short-term predictors of incident stroke in older adults. The Cardiovascular Health Study. Stroke 1996;27:1479-86
3. Paganini-Hill A. Hormone replacement therapy and stroke: risk, protection or no effect? Maturitas 2001;38:243-61
4. Pedersen AT, Lidegaard O, Kreiner S, Ottesen B. Hormone replacement therapy and risk of non-fatal stroke. Lancet 1997;350:1277-83
5. Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000;133:933-41
6. Penotti M, Farina M, Sironi L, Barletta L, Gabrielli L, Vignali M. Cerebral artery blood flow in relation to age and menopausal status. Obstet Gynecol 1996;88:106-9
7. Penotti M, Sironi L, Miglierina L, et al. The effect of tamoxifen and transdermal 17β-estradiol on cerebral arterial vessels: a randomized controlled study. Am J Obstet Gynecol 1998;178:801-5
8. Skarsgard P, van Breemen C, Laher I. Estrogen regulates myogenic tone in pressurized cerebral arteries by enhanced basal release of nitric oxide. Am J Physiol 1997;273:H2248-56
9. Ghanam K, Javellaud J, Ea-Kim L, Oudart N. Effects of treatment with 17β-estradiol on the hypercholesterolemic rabbit middle cerebral artery. Maturitas 2000;34:249-60
10. Pelligrino DA, Santizo R, Baughman VL, Wang Q. Cerebral vasodilating capacity during forebrain ischemia: effects of chronic estrogen depletion and repletion and the role of neuronal nitric oxide synthase. Neuroreport 1998;9:3285-91
11. Yang SH, Shi J, Day AL, Simpkins JW. Estradiol exerts neuroprotective effects when administered after ischemic insult. Stroke 2000;31:745-9
12. Kitazawa T, Hamada E, Kitazawa K, Gaznabi AK. Non-genomic mechanism of 17β-oestradiol-induced inhibition of contraction in mammalian vascular smooth muscle. J Physiol 1997;499:497-511
13. Jiang CW, Sarrel PM, Lindsay DC, Poole-Wilson PA, Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17β-oestradiol in vitro. Br J Pharmacol 1991;104:1033-7
14. Salom JB, Burguete MC, Perez-Asensio FJ, Torregrosa G, Alborch E. Relaxant effects of 17β-estradiol in cerebral arteries through Ca(2+) entry inhibition. J Cereb Blood Flow Metab 2001;21:422-9
15. Ogata R, Inoue Y, Nakano H, Ito Y, Kitamura K. Oestradiol-induced relaxation of rabbit basilar artery by inhibition of voltage-dependent Ca channels through GTP-binding protein. Br J Pharmacol 1996;117:351-9
16. White RE, Darkow D J, Lang JL. Estrogen relaxes coronary arteries by opening BKCa channels through a cGMP-dependent mechanism. Circ Res 1995;77:936-42
17. Otter D, Austin C. Effects of 17β-oestradiol on rat isolated coronary and mesenteric artery tone: involvement of nitric oxide. J Pharm Pharmacol 1998;50:531-8
18. Bucci M, Roviezzo F, Cicala C, Pinto A, Cirino G. 17β -Oestradiol-induced vasorelaxation in vitro is mediated by eNOS through hsp90 and akt/pkb dependent mechanism. Br J Pharmacol 2002;135:1695-700
19. Albertazzi P, Di Micco R, Zanardi E. Tibolone: a review. Maturitas 1998;30:295-305
20. Bjarnason NH, Bjarnason K, Haarbo J, Rosenquist C, Christiansen C. Tibolone: prevention of bone loss in late postmenopausal women. J Clin Endocrinol Metab 1996;81:2419-22
21. Kloosterboer HJ. Tibolone: a steroid with a tissue-specific mode of action. J Steroid Biochem Mol Biol 2001;76:231-8
22. Zoma W, Baker RS, Lang U, Clark KE. Hemodynamic response to tibolone in reproductive and nonreproductive tissues in the sheep. Am J Obstet Gynecol 2001;184:544-51
23. Grady D, Herrington D, Bittner V, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). J Am Med Assoc 2002;288:49-57
24. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002;288:321-33
25. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977;41:19-26
26. Littleton-Kearney MT, Agnew DM, Traystman RJ, Hurn PD. Effects of estrogen on cerebral blood flow and pial microvasculature in rabbits. Am J Physiol Heart Circ Physiol 2000;279:H1208-14
27. Figtree GA, Lu Y, Webb CM, Collins P. Raloxifene acutely relaxes rabbit coronary arteries in vitro by an estrogen receptor-dependent and nitric oxide-dependent mechanism. Circulation 1999;100:1095-101
28. Dalsgaard T, Larsen CR, Mortensen A, Larsen JJ, Ottesen B. New animal model for the study of postmenopausal coronary and cerebral artery function: the Watanabe heritable hyperlipidemic rabbit fed on a diet avoiding phytoestrogens. Climacteric 2002;5:178-89
29. Shaul PW. Rapid activation of endothelial nitric oxide synthase by estrogen. Steroids 1999;64:28-34
30. Rosenfeld CR, Cox BE, Roy T, Magness RR. Nitric oxide contributes to estrogen-induced vasodilation of the ovine uterine circulation. J Clin Invest 1996;98:2158-66
31. Chert Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW. Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin invest 1999;103:401-6
32. Chambliss KL, Yuhanna IS, Anderson RG, Mendelsohn ME, Shaul PW. ERβ has non-genomic action in caveolae. Mol Endocrinol 2002;16:938-46
33. Murphy JG, Khalil RA. Decreased [CA(2+)](i) during inhibition of coronary smooth muscle contraction by 17β-estradiol, progesterone, and testosterone. J Pharmacol Exp Ther 1999;291:44-52
34. Song J, Standley PR, Zhang F, et al. Tamoxifen (estrogen antagonist) inhibits voltage-gated calcium current and contractility in vascular smooth muscle from rats. J Pharmacol Exp Ther 1996;277:1444-53
35. + channel modulation in arterial smooth muscle. Acta Physiol Stand 1998;164:549-57